Tradename:

Ventolin

Ventolin

Composition:

Each 5 ml of solution contains:

Salbutamol 2 mg

Auxiliary components:

Sodium citrate, citrate acid monohydrate, hydroxapropyl methylcellulose, sodium saccharin, sodium chloride, sodium benzoate, orange flavor, purified water.

Properties:

Beta-adrenomimetic with a predominant effect on ß2-adrenergic receptors (localized, in particular, in the bronchi, myometrium, blood vessels). Prevents and relieves bronchospasm; reduces resistance in the airways, increases the vital capacity of the lungs. Prevents the release of histamine, a slow-reacting substance from mast cells and neutrophil chemotaxis factors. Compared with other drugs in this group, it has a less pronounced positive chrono- and inotropic effect on the myocardium. It causes expansion of the coronary arteries, practically does not reduce blood pressure. It has a tocolytic effect,

reducing the tone and contractile activity of the myometrium.

Indications:

Prevention and relief of bronchospasm in all forms of bronchial asthma. Reversible airway obstruction in chronic bronchitis and pulmonary emphysema, broncho-obstructive syndrome in children.

Method of administration and dosage:

Inside as a bronchodilator for adults and children over 12 years old – 2 mg (5 ml) solution 3-4 times / day, if necessary, the dose can be increased to 8 mg (20 ml) 4 times / day.

Children aged 6-12 years – 2 mg (5 ml) 3 times / day; Children 2-6 years old – 1 mg (2.5 ml) 3 times / day.

Contraindications:

Threat of miscarriage in the first and second trimesters of pregnancy, premature placent abruption, bleeding or toxicosis in the third trimester of pregnancy; children under 2 years old; hypersensitivity to salbutamol.

Precautions:

Use with caution in tachyarrhythmias and other heart rhythm disturbances, arterial hypertension, myocarditis, heart defects, aortic stenosis, diabetes mellitus, thyrotoxicosis, glaucoma, acute heart failure (subject to close medical supervision).

Increasing the dose or frequency of taking salbutamol should be carried out under medical supervision. Reduction of the interval is possible only in exceptional cases and should be strictly justified.

When using salbutamol, there is a risk of hypokalemia, therefore, during the period of treatment in patients with severe bronchial asthma, the level of potassium in the blood should be monitored. The risk of hypokalemia increases with hypoxia.

Side effects:

On the part of the cardiovascular system:

transient expansion of peripheral vessels, moderate tachycardia.

From the side of the central nervous system:

headache, dizziness, nausea, vomiting.

From the side of metabolism:

hypokalemia.

Allergic reactions:

in isolated cases – angioedema, allergic reactions in the form of skin rash, urticaria, arterial hypotension, collapse.

Others:

tremor of the hands, internal tremors, tension;

rarely – paradoxical bronchospasm, muscle cramps.

Storage:

In a cool dry place at a temperature not exceeding 30 degrees.